Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
- Comparing Advanced Modality Needs, Part 1: Manufacturing
- What Will It Take To Turn CGT Innovation Into Market Success?
- Why CMC Must Shape Critical Decisions Early In Development
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- Closing The Gap Between Modeling And GMP Predictive Control
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Nectin 4 Biomarker Testing For Oncology Clinical Programs
No validated test existed for a key tumor biomarker. See how a tissue-staining assay was built, validated, and scaled to select the right patients for a cancer trial.
-
Why Bridging Cleanroom Infrastructure And Process Equipment Design Is Critical
Conflicting regulations and poor design can misalign cleanroom mechanical systems with process equipment, creating contamination risks, compromising product quality, and delaying facility startup.
-
Successful EU MAA Submission Enabled By U.S.–EU Regulatory Collaboration
Facing EU MAA complexity? Learn how one oncology sponsor met a fixed EMA deadline through global regulatory coordination, rapid dossier adaptation, and real-time submission execution.
-
Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development
Oligonucleotide therapeutics demand precise and efficient analytical workflows. Explore how automated data processing offers a faster path to understanding metabolites and advancing development.
-
In-Line Monitoring Of Culture Medium Using Live Cell Metabolic Analyzer
Continuous in-line monitoring of glucose and lactate levels provides highly accurate, real-time data on cellular metabolism without the risks or data gaps associated with manual periodic sampling.
-
Automating High-Throughput Screens Using Patient-Derived Organoids
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
Evaluating Antibody Fragment Purification Using VH3 Resin
Explore how VH-domain targeting enables efficient purification of VH3 antibody fragments and bispecific formats, with strong recoveries and flexible wash conditions that support improved purity.
-
Cell Collection Basics For The Transplant And CGT Industries
Breakthroughs in CAR T-cell and stem cell therapies depend on mastering cellular collection. Understanding these fundamentals is vital for advancing treatment efficacy and patient outcomes.
-
Control pH Adjustment And Reduce Complexity
Learn how automated, banded pH control uses dose-and-wait logic to limit overshoot, account for mixing and buffer effects, and maintain stable setpoints across changing fill volumes.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
NEWSLETTER ARCHIVE
- 11.17.26 -- What If The Body Could Make Its Own Medicine?
- 11.17.26 -- Reducing Tech Transfer Risk In Autologous CAR T Automation
- 11.17.26 -- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- 11.16.26 -- Rethinking The Inputs Behind Scalable T-Cell Therapy
- 11.16.26 -- Rethinking Commercial Viability In CGT With Treehill Partners' Ali Pashazadeh
- What Will It Take To Turn CGT Innovation Into Market Success?
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

